Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Jun Chang

Showing results (161-170 of 236) with videos related to

Pageof 24
Sort By:
Annals of Hematology|January 3, 2021
Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaQi Chen, Xiao-Lu Zhu, Xin Zhao, et al.
Clinical and Experimental Immunology|May 13, 2022
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCTZe-Ying Fan, Ting-Ting Han, Wei Zuo, et al.
Bone Marrow Transplantation|January 26, 2022
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort studyLi-Ping Yang, Peng Zhao, Ye-Jun Wu, et al.
Bone Marrow Transplantation|April 20, 2020
Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomesQi Chen, Xin Zhao, Hai-Xia Fu, et al.
British Journal of Haematology|November 17, 2021
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantationXiang Wang, Xue-Fei Liu, Qian-Nan Shang, et al.
European Journal of Haematology|April 14, 2020
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myelomaZi-Long Wang, Yang Liu, Ya-Lan Zhou, et al.
Oncoimmunology|January 27, 2017
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized studyXiang-Yu Zhao, Xiao-Su Zhao, Yu-Tong Wang, et al.
Journal of Hematology & Oncology|July 6, 2017
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisYing-Jun Chang, Yu Wang, Yan-Rong Liu, et al.
Journal of Hematology & Oncology|April 2, 2020
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized studyYing-Jun Chang, Yu Wang, Lan-Ping Xu, et al.
Blood|June 12, 2014
Who is the best donor for a related HLA haplotype-mismatched transplant?Yu Wang, Ying-Jun Chang, Lan-Ping Xu, et al.
Pageof 24

Showing results (161-170 of 236) with videos related to

Sort By:
Pageof 24
Annals of Hematology|January 3, 2021
Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaQi Chen, Xiao-Lu Zhu, Xin Zhao, et al.
Clinical and Experimental Immunology|May 13, 2022
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCTZe-Ying Fan, Ting-Ting Han, Wei Zuo, et al.
Bone Marrow Transplantation|January 26, 2022
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort studyLi-Ping Yang, Peng Zhao, Ye-Jun Wu, et al.
Bone Marrow Transplantation|April 20, 2020
Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomesQi Chen, Xin Zhao, Hai-Xia Fu, et al.
British Journal of Haematology|November 17, 2021
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantationXiang Wang, Xue-Fei Liu, Qian-Nan Shang, et al.
European Journal of Haematology|April 14, 2020
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myelomaZi-Long Wang, Yang Liu, Ya-Lan Zhou, et al.
Oncoimmunology|January 27, 2017
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized studyXiang-Yu Zhao, Xiao-Su Zhao, Yu-Tong Wang, et al.
Journal of Hematology & Oncology|July 6, 2017
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisYing-Jun Chang, Yu Wang, Yan-Rong Liu, et al.
Journal of Hematology & Oncology|April 2, 2020
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized studyYing-Jun Chang, Yu Wang, Lan-Ping Xu, et al.
Blood|June 12, 2014
Who is the best donor for a related HLA haplotype-mismatched transplant?Yu Wang, Ying-Jun Chang, Lan-Ping Xu, et al.
Pageof 24